Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers

Aptamer-Functionalized Nanoparticles for Drug Delivery

Liu, B., Zhang, J., Liao, J., Liu, J., Chen, K., Tong, G., Yuan, P., Liu, Z., Pu, Y. D., & Liu, H. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1839 · Cited by 30

Extended phase I study of AS1411 in renal and non-small cell lung cancers

Laber, D. A., Taft, B. S., Kloecker, G. H., Bates, P. J., Trent, J. O., & Miller, D. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.13098 · Cited by 30

SDA, a DNA Aptamer Inhibiting E- and P-Selectin Mediated Adhesion of Cancer and Leukemia Cells, the First and Pivotal Step in Transendothelial Migration during Metastasis Formation

Faryammanesh, R., Lange, T., Magbanua, E., Haas, S., Meyer, C., Wicklein, D., Schumacher, U., & Hahn, U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093173 · Cited by 29

Cell-SELEX: Aptamer Selection Against Whole Cells

Shangguan, D., Bing, T., & Zhang, N. (2015) · Springer eBooks · doi:10.1007/978-3-662-46226-3_2 · Cited by 29

SELEX_DB: a database on in vitro selected oligomers adapted for recognizing natural sites and for analyzing both SNPs and site-directed mutagenesis data

Ponomarenko, J. V. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.195 · Cited by 28

Morph-X-Select: Morphology-Based Tissue Aptamer Selection for Ovarian Cancer Biomarker Discovery

Wang, H., Li, X., Volk, D. E., Lokesh, G. L.-R., Elizondo-Riojas, M.-Á., Li, L., Nick, A. M., Sood, A. K., Rosenblatt, K. P., & Gorenstein, D. G. (2016) · BioTechniques · doi:10.2144/000114473 · Cited by 28

Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics

Zamay, A. S., Сергеевна, З. Г., Kolovskaya, O. S., Zamay, T. N., & Berezovski, M. V. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55947-6_3 · Cited by 28

A novel molecular marker of breast cancer stem cells identified by cell-SELEX method

Lu, M., Zhou, L., Zheng, X., Quan, Y., Wang, X., Zhou, X., & Ren, J. (2015) · Cancer Biomarkers · doi:10.3233/cbm-140450 · Cited by 26

Structure/activity studies of the anti‐MUC1 monoclonal antibody C595 and synthetic MUC1 mucin‐core‐related peptides and glycopeptides

Spencer, D. I. R., Missailidis, S., Denton, G., Murray, A., Brady, K., Matteis, C. I. D., Searle, M. S., Tendler, S. J. B., & Price, M. R. (1999) · Biospectroscopy · doi:10.1002/(sici)1520-6343(1999)5:2 · Cited by 25

Aptahistochemistry in diagnostic pathology: technical scrutiny and feasibility

Bukari, B. A., Citartan, M., Ch’ng, E. S., Bilibana, M. P., Rozhdestvensky, T. S., & Tang, T. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-017-1561-9 · Cited by 25

Cellular Internalization and Cytotoxicity of Aptamers Selected from Lung Cancer Cell

Xu, L., Zhang, Z., Zhao, Z., Liu, Q., Tan, W., & Fang, X. (2013) · American Journal of Biomedical Sciences · doi:10.5099/aj130100047 · Cited by 23

Aptamer-Mediated Cancer Gene Therapy

Xiang, D., Shigdar, S. L., Qiao, G. G., Zhou, S., Li, Y., Wei, M. Q., Qiao, L., Shamaileh, H. A., Zhu, Y., Zheng, C., et al. (2015) · Current Gene Therapy · doi:10.2174/1566523214666141224095105 · Cited by 23

Selection of a novel DNA thioaptamer against HER2 structure

Hu, Y., Duan, J., Cao, B., Zhang, L., Lu, X., Wang, F., Yao, F., Zhu, Z., Yuan, W., Wang, C., et al. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1292-0 · Cited by 22

Cancer heterogeneity determined by functional proteomics

Szász, A. M., Győrffy, B., & Marko‐Varga, G. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.026 · Cited by 22

Aptamer technology for tracking cells’ status & function

Wiraja, C., Yeo, D., Lio, D. C. S., Labanieh, L., Lu, M., Zhao, W., & Xu, C. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-33 · Cited by 21

A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function

White, R. R., Roy, J. A., Viles, K. D., Sullenger, B. A., & Kontos, C. D. (2008) · Angiogenesis · doi:10.1007/s10456-008-9122-4 · Cited by 20

Aptamers Binding to c-Met Inhibiting Tumor Cell Migration

Piater, B., Doerner, A., Guenther, R., Kolmar, H., & Hock, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142412 · Cited by 20

Aptamer-Functionalized Nanoparticles as “Smart Bombs”: The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment

Benedetto, G., Vestal, C. G., & Richardson, C. A. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0371-z · Cited by 16

Aptamers Selected by Cell-SELEX for Molecular Imaging

Jin, C. Y., Zheng, J., Li, C., Qiu, L., Zhang, X., & Tan, W. (2015) · Journal of Molecular Evolution · doi:10.1007/s00239-015-9716-6 · Cited by 16

Binding of an aptamer to the N-terminal fragment of VCAM-1

Chauveau, F., Aissouni, Y., Hamm, J., Boutin, H., Libri, D., Ducongè, F., & Tavitian, B. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.046 · Cited by 15

Oligonucleotide-mediated inhibition of CD28 expression induces human T cell hyporesponsiveness and manifests impaired contact hypersensitivity in mice

Tam, R. C., Phan, U., Milovanović, T., Pai, B., Lim, C. S., Bard, J., & He, L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.200 · Cited by 14

Aptamers in Targeted Nanotherapy

Mathew, A., Maekawa, T., & Kumar, D. S. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150413153525 · Cited by 14

Activity and Mechanism of Action of AS1411 in Acute Myeloid Leukemia Cells.

Chen, W., Sridharan, V., Soundararajan, S., Otake, Y., Stuart, R. K., Jones, D., & Fernandes, D. (2007) · Blood · doi:10.1182/blood.v110.11.1604.1604 · Cited by 13

Results from a Phase IIa Study of the Anti-CXCL12 Spiegelmer Olaptesed Pegol (NOX-A12) in Combination with Bendamustine/Rituximab in Patients with Chronic Lymphocytic Leukemia

Steurer, M., Montillo, M., Scarfò, L., Mauro, F. R., Andel, J., Wildner, S. M., Trentin, L., Janssens, A. M., Burgstaller, S., Kruschinski, A., et al. (2014) · Blood · doi:10.1182/blood.v124.21.1996.1996 · Cited by 12

The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study

Vavalle, J. P., Rusconi, C. P., Zelenkofske, S. L., Wargin, W. A., Ortel, T. L., Alexander, J. H., Povsic, T. J., & Becker, R. C. (2014) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-014-1081-6 · Cited by 10

An anticoagulant too good to be true for revascularisation

Verheugt, F. W. A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00727-8 · Cited by 9

Isolation of RNA aptamers against human Toll-like receptor 3 ectodomain

Watanabe, T., Ito, K., Matsumoto, M., Seya, T., Nishikawa, S., Hasegawa, T., & Fukuda, K. (2006) · Nucleic Acids Symposium Series · doi:10.1093/nass/nrl125 · Cited by 8

Therapeutic Applications of Ribozymes and Riboswitches

Lafontaine, D. A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-730-3 · Cited by 6

Synthetic Antibodies

(2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6857-2 · Cited by 5

Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice

Lemech, C., & Arkenau, H. (2011) · Cancers · doi:10.3390/cancers3021844 · Cited by 2

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073

Aptamer-Based Detection of Circulating Targets for Precision Medicine

Wu, L., Wang, Y., Xu, X., Liu, Y., Lin, B., Zhang, M., Zhang, J., Wan, S., Yang, C. J., & Tan, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01140 · Cited by 706

Recent Advances in Aptamer Discovery and Applications

Zhang, Y., Lai, B. S., & Juhas, M. (2019) · Molecules · doi:10.3390/molecules24050941 · Cited by 689

Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development

Wang, T., Chen, C., Larcher, L. M., Barrero, R. A., & Veedu, R. N. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.001 · Cited by 538

Perspective on the Future Role of Aptamers in Analytical Chemistry

Wu, Y., Belmonte, I., Sykes, K. S., Xiao, Y., & White, R. J. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03853 · Cited by 173

Nucleic acid aptamers targeting cell-surface proteins

Dua, P., Kim, S., & Lee, D.-K. (2011) · Methods · doi:10.1016/j.ymeth.2011.02.002 · Cited by 122

Production of aptamers by cell-SELEX and their applications in cancer biomarker identification.

Zhao, J., He, J. G., Zhong, L., Huang, Y., & Zhao, Y. (2020) · PubMed · Cited by 5

Using aptamers to identify and enter cells.

Chu, T. C., Ebright, J. N., & Ellington, A. D. (2007) · PubMed · Cited by 20

Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof

Shigdar, S. L., Agnello, L., Fedele, M., Camorani, S., & Cerchia, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010028 · Cited by 49

Methods To Identify Aptamers against Cell Surface Biomarkers

Cibiel, A., Dupont, D. M., & Ducongè, F. (2011) · Pharmaceuticals · doi:10.3390/ph4091216 · Cited by 65